The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model - Concepedia

Concepedia

Publication | Open Access

The cost-effectiveness and public health benefit of nalmefene added to psychosocial support for the reduction of alcohol consumption in alcohol-dependent patients with high/very high drinking risk levels: a Markov model

DOI Full Paper Access

42

Citations

25

References

2014

Year

Philippe Laramée, Thor‐Henrik Brodtkorb, Nora Rahhali, C Knight, Carolina Barbosa, C. François, Mondher Toumi, Jean‐Bernard Daeppen, Jürgen Rehm

Abstract

This cost-effectiveness analysis was developed based on data from three randomised clinical trials: ESENSE 1 (NCT00811720), ESENSE 2 (NCT00812461) and SENSE (NCT00811941).

References

	Year	Citations

Page 1